Last reviewed · How we verify
NCT05952167: TracCerv2
Evaluation of the Impact of Tractions vs. Placebo Tractions in Patients With Cervical Radiculopathy
NA trial testing Intensive cervical traction protocol in Radiculopathy in 206 participants. Currently enrolling.
25 December 2030
Quick facts
| Lead sponsor | Centre Hospitalier Departemental Vendee |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 206 |
| Start date | 25 March 2024 |
| Primary completion | 25 December 2030 |
| Estimated completion | 25 September 2031 |
| Sites | 8 locations across France |
Drugs / interventions tested
- Intensive cervical traction protocol
- Intensive cervical traction protocol - placebo
Conditions studied
- Radiculopathy — all drugs for Radiculopathy →
- Cervical — all drugs for Cervical →
Sponsor
Centre Hospitalier Departemental Vendee
Who can join
18 and older, any sex, with Radiculopathy or Cervical. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cervical radiculopathy is a common disease related to compression of the nerve roots of the spine (prevalence: 3.5/1000). Dysfunction and pain are the main repercussions and can lead to time off work and high costs in terms of treatment. Second-line surgical treatments appear to be less effective and present risks of side effects. In the first instance, treatments are conservative and include medication but above all physiotherapy with manual therapy, muscle exercises and cervical traction. These cervical tractions performed by a physiotherapist require little equipment and are inexpensive compared with the surgical alternative. They involve stretching the cervical spine and soft tissues to open the intervertebral foramen and mobilise the facet joints. Several authors have written summaries of their interest. Thoomes reports two studies and describes an absence of effect. In a meta-analysis, Romeo et al. added three more recent studies to the previous review and concluded that traction is effective, highlighting an "effect-dose" relationship. These recent results therefore seem to reverse the recommendations made barely two years later. Nevertheless, almost all the studies compared "manual therapy + exercises" with "manual therapy + exercises + cervical traction". Only Young et al. tested "manual therapy + exercises + cervical traction at an effective weight" compared to "manual therapy + exercises + cervical traction placebo at an ineffective weight". The study did not reveal any difference between the groups. However, several limitations appear in this study when comparing the protocol to studies that have shown efficacy. The main limitation is the low intensity (i.e. protocol with fewer sessions and longer duration). These clinical limitations may explain the lack of evidence of a positive outcome. Following on from a preliminary study evaluating an intensive cervical traction protocol over five days, and in order to discern the effect specific to the treatment (specific effect) and the effect independent of the nature of the treatment (contextual effect), the investigators wish to evaluate the impact of this intensive protocol by comparing it with placebo traction. In current practice, treatment varies between establishments. The paucity of studies on cervical traction in radiculopathy has resulted in routine use being guided by habit rather than evidence. It remains a clinical question which raises a major issue requiring a robust experimental design. Ultimately, this study follows on from a preliminary study and is part of a comprehensive research project aimed at proposing new recommendations for the use of traction in patients suffering from cervical radiculopathy. The investigators are investigating the impact of an intensive traction vs. placebo traction protocol in patients with cervical radiculopathy.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The effect of mechanical traction on cervical radiculopathy: protocol for the TracCerv2 single-blind, randomised controlled trial.
Cormier G, Moreau C, Scalisi E, Pastor L, et al · · 2025 · cited 2× · PMID 39953437 · DOI 10.1186/s12906-025-04801-5
Verify or expand the search:
- PubMed search for NCT05952167
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Radiculopathy
Currently open trials in the same condition.
- NCT06956664 — Exercise Therapy After Caudal Epidural Steroid Injection · NA · recruiting
- NCT05817747 — Strategic Use of Big Data in Spine Surgery - Testing Digital Prediction of Outcome in Clinical Praxis · NA · recruiting
- NCT05696470 — Fusion Rates of 3D Printed Porous Titanium Cages in Three and Four Level ACDFs · active not recruiting
- NCT05035693 — Post Market Clinical Follow up Study With the Cervical Disc Prothesis MOVE®-C · NA · recruiting
- NCT04273828 — Impact of Muscle Degeneration in Chronic Low Back Pain · recruiting
Other Centre Hospitalier Departemental Vendee trials
Trials by the same sponsor.
- NCT07489820 — Evaluation of the Efficacy of Negative Pressure Wound Therapy on Perineal Healing Following Abdominoperineal Amputation · NA · not yet recruiting
- NCT07313293 — Impact of Foot Reflexology on Nausea After Obesity Surgery · NA · recruiting
- NCT07314632 — Prospective Study in Laser Treatment of Pilonidal Cysts · recruiting
- NCT07340060 — Statistical Association Between Bicarbonate Levels and Death or Admission to Intensive Care Within 48 Hours in Patients · recruiting
- NCT07228767 — Assessment of Surgeons' Mental Fatigue Based on Operating Time · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05952167 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Departemental Vendee
- Last refreshed: 15 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05952167.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing